9 November 2022
Oxford Metrics plc
("Oxford Metrics" or the "Group")
Notification of Results
Oxford Metrics plc (LSE: OMG), the smart sensing software company servicing life sciences, entertainment and engineering markets, expects to report its preliminary results for the financial year ended 30 September 2022 on Tuesday 6 December 2022.
For further information please contact:
| Oxford Metrics | +44 (0) 1865 261860 |
| Nick Bolton, CEO | |
| David Deacon, CFO | |
|
|
|
| Numis Securities Limited | +44 (0)20 7260 1000 |
| Simon Willis / Hugo Rubinstein / Tejas Padalkar | |
|
|
|
| FTI Consulting | +44 (0)20 3727 1000 |
| Matt Dixon / Emma Hall / Jamille Smith / Jemima Gurney | |
| | |
About Oxford Metrics
Oxford Metrics develops software that enables the interface between the real world and its virtual twin. Our smart sensing software helps over 10,000 customers in more than 70 countries, including all of the world's top 10 games companies and all of the top 20 universities worldwide. Founded in 1984, we started our journey in healthcare, expanded into entertainment, winning an OSCAR® and an Emmy®, then moved into defence and engineering. We have a track record of creating value by incubating, growing and then augmenting through acquisition, unique technology businesses.
The Group trades through its market-leading division: Vicon. Vicon is a world leader in motion measurement analysis to thousands of customers worldwide, including Guy's Hospital, Industrial Light & Magic, MIT and NASA.
The Group is headquartered in Oxford with offices in California, Colorado, and Auckland. Since 2001, Oxford Metrics (LSE: OMG), has been a quoted company listed on AIM, a market operated by the London Stock Exchange. For more information about Oxford Metrics, visit www.oxfordmetrics.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
